On behalf of the Board of Directors of Supergenics (“Board”), Sierac Corporate Advisers Sdn Bhd (“SCA”) wishes to announce that the Company proposes to undertake a proposed private placement of up to 11,568,908 new ordinary shares in Supergenics (“Supergenics Shares” or “Shares”) (“Placement Shares”), representing up to approximately 10% of the total number of issued Supergenics Shares to independent third party investor(s) to be identified, at an issue price to be determined and announced at a later date, in accordance with the general mandate pursuant to Sections 75 and 76 of the Act obtained at the 7th annual general meeting (“AGM”) of the Company.

Kindly refer to the attachment for further details on the Proposed Private Placement.

This announcement is dated 30 April 2025.